全文获取类型
收费全文 | 147篇 |
免费 | 9篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 17篇 |
口腔科学 | 2篇 |
临床医学 | 13篇 |
内科学 | 12篇 |
皮肤病学 | 2篇 |
神经病学 | 1篇 |
特种医学 | 3篇 |
外科学 | 76篇 |
预防医学 | 7篇 |
眼科学 | 2篇 |
药学 | 17篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 2篇 |
2021年 | 1篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 3篇 |
2017年 | 4篇 |
2016年 | 1篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 6篇 |
2012年 | 10篇 |
2011年 | 11篇 |
2010年 | 4篇 |
2009年 | 9篇 |
2008年 | 8篇 |
2007年 | 11篇 |
2006年 | 9篇 |
2005年 | 5篇 |
2004年 | 8篇 |
2003年 | 9篇 |
2002年 | 12篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 9篇 |
1998年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1979年 | 1篇 |
排序方式: 共有156条查询结果,搜索用时 15 毫秒
41.
Diagnostic Value of Monitoring Human Cytomegalovirus Late pp67 mRNA Expression in Renal-Allograft Recipients by Nucleic Acid Sequence-Based Amplification 总被引:5,自引:10,他引:5 下载免费PDF全文
Marinus J. Blok Valere J. Goossens Sabina J. V. Vanherle Bert Top Nicole Tacken Jaap M. Middeldorp Maarten H. L. Christiaans Johannes P. van Hooff Cathrien A. Bruggeman 《Journal of clinical microbiology》1998,36(5):1341-1346
The diagnostic value of monitoring human cytomegalovirus (HCMV) late pp67 mRNA expression by nucleic acid sequence-based amplification (NASBA) after renal-allograft transplantation was evaluated. RNAs were isolated from 489 whole-blood specimens of 42 patients for the specific amplification of the late pp67 (UL65) mRNA. NASBA results were compared to results from the pp65 antigenemia assay, virus isolation by cell culture, and serology. The sensitivity value for NASBA proved to be higher than that for the antigenemia assay (50 versus 35%) for the detection of HCMV infection, while the sensitivity values of cell culture and NASBA were comparable (54 and 50%, respectively). NASBA detected the onset of HCMV infection simultaneously with cell culture and the antigenemia assay. Both the antigenemia assay and NASBA are very specific (100%) and highly predictive (100%) for the onset of HCMV infection. Antiviral therapy with ganciclovir resulted in negative results for cell culture, the antigenemia assay, and NASBA. In conclusion, monitoring HCMV pp67 mRNA expression by NASBA is a highly specific method for the detection of HCMV infection in renal-allograft recipients and is more sensitive than the antigenemia assay. Furthermore, NASBA can be used to monitor the progression of HCMV infections and the effect of antiviral therapy on viral activity. 相似文献
42.
Y.J. Kraat F.S. Stals M.H. Christiaans T. Lazzarotto M.P. Landini C.A. Bruggeman 《Journal of medical virology》1996,48(3):289-294
The value of IgM detection for the early diagnosis of an active cytomegalovirus (CMV) infection in renal transplant recipients was evaluated prospectively. Sequential serum samples obtained from 22 allograft recipients with active CMV infection were tested for the presence of CMV-specific immunoglobulin M antibodies (IgM) by an enzyme-linked immunosorbent assay (ELISA) and a microparticle enzyme immunoassay (MEIA) and were compared with the Western-immunoblotting technique (IB). The time course of CMV IgM antibody detection was evaluated in relation to the shell vial assay (SVA), CMV disease, and immunosuppressive regimen. By IB, IgM antibodies against the capsid protein ppUL80a and the basic matrix phosphoprotein ppUL32 were detected in all 22 recipients with active CMV infection. Using the MEIA and the ELISA, the presence of CMV IgM antibodies was detected in 17 (77%) and ten (46%) of these 22 recipients, respectively. The SVA was the earliest parameter for detection of primary CMV infection in seven of nine (78%) recipients, in contrast to two of 13 (15%) patients with recurrent CMV infection (P < .05). The detection of IgM antibodies by IB was the earliest parameter for detection of recurrent CMV infection in seven out of 13 (54%) recipients in contrast to one out of nine (11%) patients with primary CMV infection (P < .05). During a primary CMV infection, the development of an abundant IgM antibody response was associated with recovery from CMV disease and the end of the viremic phase. © 1996 Wiley-Liss, Inc. 相似文献
43.
Jeroen Aalten Maarten H. Christiaans Hans de Fijter Ronald Hené Jaap Homan van der Heijde Joke Roodnat Janto Surachno Andries Hoitsma 《Transplant international》2006,19(11):901-907
To determine short- and long-term patient and graft survival in obese [body mass index (BMI) >or= 30 kg/m(2)] and nonobese (BMI < 30 kg/m(2)) renal transplant patients we retrospectively analyzed our national-database. Patients 18 years or older receiving a primary transplant after 1993 were included. A total of 1,871 patients were included in the nonobese group and 196 in the obese group. In the obese group there were significantly more females (52% vs. 38.6%, P < 0.01) and patients were significantly older [52 years (43-59) vs. 48 years (37-58); P < 0.05]. Patient survival and graft survival were significantly decreased in obese renal transplant recipients (1 and 5 year patient survival were respectively 94% vs. 97% and 81% vs. 89%, P < 0.01; 1 and 5 year graft survival were respectively 86% vs. 92% and 71% vs. 80%, P < 0.01). Initial BMI was an independent predictor for patient death and graft failure. This large retrospective study shows that both graft and patient survival are significantly lower in obese renal transplant recipients. 相似文献
44.
Cardiovascular disease is the leading cause of death in renal transplant recipients. Arterial wall properties are surrogate markers for arteriosclerosis. Previous investigations have shown that the cardiovascular risk profile is better with tacrolimus compared to cyclosporine. Renal function, blood pressure, and lipid levels improve. The hypothesis is that arterial wall properties will improve after conversion from cyclosporine to tacrolimus. Thirty-four stable renal recipients were converted from cyclosporine microemulsion to tacrolimus without changing concomitant medication. Before and after conversion we performed wall track ultrasounds of the carotid and the brachial arteries; pulse wave velocity (PWV); laboratory investigations; 24-hour ABPM; estimates of renal function; and Framingham risk scores. After conversion the 24-hour ambulatory blood pressure monitoring (ABPM) did not change. Total cholesterol, LDL cholesterol, and triglycerides improved significantly. Renal function (Cockroft) improved. There were no significant changes in arterial wall properties, or in PWV. Framingham comparative risk scores improved only significantly in patients not receiving statins. In conclusion, 3 months after conversion from cyclosporine to tacrolimus total cholesterol, LDL cholesterol, and triglycerides were significantly decreased and renal function significantly improved. Contrary to expectation, ABPM did not change, probably due to prolonged use (>10 years) of cyclosporine. There was also no difference in arterial wall properties. 相似文献
45.
Toric phakic intraocular lens: European multicenter study 总被引:7,自引:0,他引:7
Dick HB Alió J Bianchetti M Budo C Christiaans BJ El-Danasoury MA Güell JL Krumeich J Landesz M Loureiro F Luyten GP Marinho A Rahhal MS Schwenn O Spirig R Thomann U Venter J 《Ophthalmology》2003,110(1):150-162
OBJECTIVE: To evaluate safety, efficacy, predictability, stability, complications, and patient satisfaction after implantation of Artisan toric phakic intraocular lenses (TPIOLs) for the correction of myopia or hyperopia with astigmatism. DESIGN: Prospective, nonrandomized, comparative (self-controlled) multicenter trial. PARTICIPANTS: Seventy eyes of 53 patients (mean, 35 years; range, 22-59 years) with preoperative spherical equivalent between +6.50 and -21.25 diopters (D) and cylinder between 1.50 and 7.25 D. METHODS: Seventy eyes underwent implantation of a TPIOL with an optical zone of 5.0 mm (Artisan, Ophtec, Groningen, The Netherlands). The dioptric power of the intraocular lens was calculated by considering refraction, keratometry, and anterior chamber depth. The follow-up was 6 months in all cases. Lenses were available in powers ranging from +12.0 D to -23.5 D (spherical equivalent) in 0.5-D increments, with additional cylinder from 1.0 D to 7.0 D, also in 0.5-D increments. MAIN OUTCOME MEASURES: The main parameters assessed were best spectacle-corrected visual acuity (BSCVA), uncorrected visual acuity (UCVA), refraction, endothelial cell count (ECC), intraocular pressure, slit-lamp biomicroscopy, indirect ophthalmoscopy, subjective complaints, and patient satisfaction. RESULTS: Eyes were divided into group A, myopia (n = 48), with an average preoperative spherical equivalent of -8.90 +/- 4.52 D, and group B, hyperopia (n = 22), with an average preoperative spherical equivalent of +3.25 +/- 1.98 D. No eyes in either group experienced a loss in BSCVA, and 46 eyes gained 1 or more lines of their preoperative BSCVA. In 62 eyes (88.6%), UCVA was 20/40 or better. There was a significant reduction in spherical errors and astigmatism in all cases after surgery. All eyes of both groups were within +/-1.00 D of target refraction, and 51 eyes (72.9%) were within +/-0.50 D of target refraction. There was a 4.5% mean total loss of ECC during the first 6 months. No serious complications were observed. Overall patient satisfaction was very high. CONCLUSIONS: Six-month clinical trial results demonstrate that implantation of the Artisan TPIOL safely, predictably, and effectively reduced or eliminated high ametropia and astigmatism with one procedure. The refractive effect was stable at 6 months after surgery. 相似文献
46.
Lenaers J Christiaans M van Heurn E van Hooff H van den Berg-Loonen E 《Transplantation》2006,81(4):614-619
BACKGROUND: Donor-directed antibodies (DDA) can be formed in recipients after transplantation. There is not much known about their appearance in relation to the time after transplantation, nor the duration between transplantation and failure. METHODS: DDA formation was retrospectively analyzed in patients transplanted between 1992 and 2004. Thirty-two nonimmunized first transplant recipients with transplantectomy within 4 weeks (median 6 days) were analyzed. Posttransplant sera were screened for HLA class I and II by flow cytometry (FC), ELISA, and cytotoxicity. All patients except one were treated with CNI (calcineurin inhibitor)-based immunosuppression. RESULTS: Analysis was performed on the basis of FC results. In total, 16 of 32 patients became positive for DDA class I and/or II (50%). All antibodies were detected after transplantectomy. Class I and II antibodies were produced in 15 and 10 recipients, respectively. Multivariate regression analysis showed DDA positivity to be predicted by donor age (P=0.05). DDA were shown in patients who lost their graft due to immunological reasons but in a comparable percentage also in patients with nonimmunological graft loss. CONCLUSIONS: DDA after early transplantectomy appeared frequently but later than expected. In view of the growing number of marginal donors and the possible necessity of retransplantation, it is considered important to prolong the time of serum sampling and screening to at least 4 months. Immunization might escape attention when serum screening is restarted only from the time the patient is again referred to the waiting list. 相似文献
47.
48.
High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation 总被引:2,自引:0,他引:2
Gelens MA Christiaans MH van Heurn EL van den Berg-Loonen EP Peutz-Kootstra CJ van Hooff JP 《Transplantation》2006,82(9):1221-1223
Morbidity and mortality due to cardiovascular disease are major problems after renal transplantation. The effects of three immunosuppressive protocols on cardiovascular end points were investigated in a single-center, randomized, parallel (1-1-1) group. Acute rejection was a secondary safety endpoint. Groups were as follows: group one, tacrolimus+sirolimus; group two, tacrolimus+mycophenolate mofetil (MMF); group three, sirolimus+MMF+daclizumab. All groups received two days methylprednisolone only. The Ethical Committee demanded an interim analysis when 50% of the patients were included. In this analysis, 54 patients with a median follow-up of 9.2 months were studied. The Kaplan-Meyer analysis showed a difference in rejection free survival between group one (82%) and group three (34%, P=0.03) and between groups one and two (tacrolimus-based, 76%) and group three (calcineurin-free, 34%, P=0.04). Calcineurin-free immunosuppression with two days of steroids only showed an unacceptable high incidence of acute rejection and re-rejection, and the study had to be stopped. 相似文献
49.
Wallén EA Christiaans JA Forsberg MM Venäläinen JI Männistö PT Gynther J 《Journal of medicinal chemistry》2002,45(20):4581-4584
New dicarboxylic acid bis(L-prolyl-pyrrolidine) amides were synthesized, and their inhibitory activity against prolyl oligopeptidase from pig brain was tested in vitro. As compared with earlier described prolyl oligopeptidase inhibitors, these new compounds have in common an L-prolyl-pyrrolidine moiety, but the typical lipophilic acyl end group is replaced by another L-prolyl-pyrrolidine moiety connected symmetrically with a short dicarboxylic acid linker. These compounds are a new type of peptidomimetic prolyl oligopeptidase inhibitor. 相似文献
50.
Job A. J. Verdonschot Els K. Vanhoutte Godelieve R. F. Claes Apollonia T. J. M. Helderman‐van den Enden Janneke G. J. Hoeijmakers Debby M. E. I. Hellebrekers Amber de Haan Imke Christiaans Ronald H. Lekanne Deprez Hanne M. Boen Emeline M. van Craenenbroeck Bart L. Loeys Yvonne M. Hoedemaekers Carlo Marcelis Marlies Kempers Esther Brusse Jaap I. van Waning Annette F. Baas Dennis Dooijes Folkert W. Asselbergs Daniela Q. C. M. Barge‐Schaapveld Pieter Koopman Arthur van den Wijngaard Stephane R. B. Heymans Ingrid P. C. Krapels Han G. Brunner 《Human mutation》2020,41(6):1091-1111
Filamin C (FLNC) variants are associated with cardiac and muscular phenotypes. Originally, FLNC variants were described in myofibrillar myopathy (MFM) patients. Later, high‐throughput screening in cardiomyopathy cohorts determined a prominent role for FLNC in isolated hypertrophic and dilated cardiomyopathies (HCM and DCM). FLNC variants are now among the more prevalent causes of genetic DCM. FLNC‐associated DCM is associated with a malignant clinical course and a high risk of sudden cardiac death. The clinical spectrum of FLNC suggests different pathomechanisms related to variant types and their location in the gene. The appropriate functioning of FLNC is crucial for structural integrity and cell signaling of the sarcomere. The secondary protein structure of FLNC is critical to ensure this function. Truncating variants with subsequent haploinsufficiency are associated with DCM and cardiac arrhythmias. Interference with the dimerization and folding of the protein leads to aggregate formation detrimental for muscle function, as found in HCM and MFM. Variants associated with HCM are predominantly missense variants, which cluster in the ROD2 domain. This domain is important for binding to the sarcomere and to ensure appropriate cell signaling. We here review FLNC genotype–phenotype correlations based on available evidence. 相似文献